DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 894 filers reported holding DANAHER CORPORATION in Q1 2014. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $2,866,000 | -5.1% | 27,793 | 0.0% | 1.12% | +44.4% |
Q3 2018 | $3,019,000 | +10.1% | 27,793 | 0.0% | 0.77% | -1.5% |
Q2 2018 | $2,742,000 | +0.8% | 27,793 | 0.0% | 0.78% | +125.9% |
Q1 2018 | $2,721,000 | +5.5% | 27,793 | 0.0% | 0.35% | +1.5% |
Q4 2017 | $2,579,000 | +8.2% | 27,793 | 0.0% | 0.34% | +8.9% |
Q3 2017 | $2,384,000 | +1.7% | 27,793 | 0.0% | 0.31% | +5.0% |
Q2 2017 | $2,345,000 | -1.3% | 27,793 | 0.0% | 0.30% | -1.3% |
Q1 2017 | $2,377,000 | +9.9% | 27,793 | 0.0% | 0.30% | +57.0% |
Q4 2016 | $2,163,000 | -0.7% | 27,793 | 0.0% | 0.19% | +13.5% |
Q3 2016 | $2,178,000 | -22.4% | 27,793 | 0.0% | 0.17% | -18.7% |
Q2 2016 | $2,807,000 | -55.2% | 27,793 | -57.9% | 0.21% | -53.1% |
Q1 2016 | $6,262,000 | +1.6% | 66,019 | -0.5% | 0.45% | +4.4% |
Q4 2015 | $6,164,000 | -8.5% | 66,375 | -16.1% | 0.43% | -9.1% |
Q3 2015 | $6,740,000 | -15.5% | 79,104 | -15.1% | 0.47% | -4.7% |
Q2 2015 | $7,977,000 | +49.6% | 93,209 | +48.4% | 0.49% | +74.2% |
Q1 2015 | $5,331,000 | +135.6% | 62,803 | +137.8% | 0.28% | +141.9% |
Q4 2014 | $2,263,000 | +11.0% | 26,408 | -1.6% | 0.12% | +12.5% |
Q3 2014 | $2,038,000 | -40.3% | 26,831 | -38.2% | 0.10% | -34.2% |
Q2 2014 | $3,415,000 | +317.5% | 43,381 | +297.6% | 0.16% | +338.9% |
Q1 2014 | $818,000 | – | 10,912 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |